We evaluated the serum CEA, Cyfra21-1, HE4, IL-8, MIF, TNF-α and VEGF in all non-smoking LC patients with NSCLC and HC groups. This evidence concerns the gene CEACAM5 and laryngotracheoesophageal cleft.